Drug Profile
Research programme: glucagon-like peptide-1 agonists - Serometrix
Alternative Names: SX-GLP1Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Serometrix
- Class
- Mechanism of Action Glucagon-like peptide 1 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Type-2-diabetes-mellitus in USA
- 12 Jul 2016 Early research in Type-2 diabetes mellitus in USA (unspecified route)